OAG
JNJ icon

Oakmont Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Oakmont Advisory Group’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$398K Buy
1,565
+129
+9% +$30.1K 0.33% 75
2026
Q1 		$351K Sell
1,436
-234
-14% -$54.5K 0.36% 75
2025
Q4 		$346K Buy
+1,670
New +$330K 0.37% 70

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Oakmont Advisory Group's JNJ Position: Q2 2026 in Review

Oakmont Advisory Group increased its Johnson & Johnson (JNJ) stake by 9% in Q2 2026, buying an estimated $30.1K and bringing the position to 1,565 shares worth $398K. The position accounts for 0.33% of the portfolio, ranked #75.

Oakmont Advisory Group first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,650 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Oakmont Advisory Group held 1,565 shares of Johnson & Johnson worth $398K as of Q2 2026.
  • Oakmont Advisory Group bought 129 Johnson & Johnson shares in Q2 2026, an estimated $30.1K.
  • Johnson & Johnson made up 0.33% of Oakmont Advisory Group's portfolio in Q2 2026, its #75 holding.
  • Oakmont Advisory Group first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 4,650 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Oakmont Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.